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Basics of isolation and cultivation of 
chondrocytes according to good laboratory 
practice
Resumen
Objetivos: El objetivo del presente estudio era determinar si los condrocitos aislados de cinco pacientes an-
cianos (edad media 63 años) con artrosis (grado 3) mantienen su proliferación y potencial condrogénico. El 
aislamiento y cultivo de condrocitos fueron llevados a cabo de acuerdo a los estándares de buenas prácticas 
de laboratorio.
Métodos: Los condrocitos fueron aislados de una biopsia de cartílago mediante digestión enzimática. El 
cultivo fue llevado a cabo en un ambiente controlado (sala blanca). La caracterización del fenotipo de los 
condrocitos se logró mediante análisis de citometría de flujo.
Resultados: Tras tres semanas de cultivo se podían observar estructuras poligonales propias de los condro-
citos, pero también se observaba morfología de tipo fibroblasto en el cultivo. El análisis de la citometría 
de flujo reveló que el fenotipo de los condrocitos cultivados tras el primer pasaje era positivo para CD44 
(98,92%), CD90 (97,11%) y negativo para el marcador hematopoyético CD45 (0,10%).
Conclusiones: Los condrocitos articulares humanos obtenidos de cinco pacientes ancianos con artrosis man-
tenían un fenotipo condrocitario y podrían ser potencialmente utilizados para la implantación autóloga. Las 
condiciones para el cultivo fueron establecidas de acuerdo a los estándares de buenas prácticas de labora-
torio para así minimizar el riesgo de contaminación celular in vitro.
Abstract
Objectives: The objective of the present study was to determine if chondrocytes isolated from human car-
tilage of five elderly patients (middle age 63) with osteoarthritis (stage 3) maintain their proliferation and 
chondrogenic potential. Isolation and cultivation of chondrocytes was performed according to good labora-
tory practice (GLP) standards. 
Methods: Chondrocytes were isolated from cartilage biopsy by enzymatic digestion. Cultivation of cells 
was performed in a controlled environment (cleanroom). Phenotype characterization of chondrocytes was 
achieved by flow cytometry analysis. 
Results: Three weeks after cultivation polygonal structures typical for chondrocytes were observed, but 
spindle/fibroblast like morphology was also detected in culture. Flow cytometric analysis showed that chon-
drocytes were positive for CD44 (98,35% ± 0,50), CD90 (97,15% ± 0,13) after first passage (P1) and the cells 
were negative for hematopoietic marker CD45 (0,21% ± 0,11). 
Conclusions: Human articular chondrocytes obtained from five elderly patients with osteoarthritis main-
tained a chondrocyte phenotype and could be potentially used for autologous implantation. We have stan-
dardized the conditions for cultivation according to GLP standards to minimize the risk of in vitro cell con-
tamination.
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INTRODUCTION
Cartilage tissue is composed of chondrocytes embedded 
within a dense extracellular matrix (ECM). It has poor 
autonomous regeneration capacity, mainly due to its avascular 
nature. Another factor contributing to poor regenerative 
capacity of articular cartilage (AC) is the restricted number 
of ECM producing cells. The percentage of highly specialized 
chondrocytes in cartilage tissue is only 1–3% (1). Chondrocytes 
are unable to migrate to a site of injury; they are able to 
synthesize fibrous repair tissue, but not sufficiently to fill 
even small defects (<3 mm in diameter) with a cartilage-like 
matrix, the defects are not repaired and remains permanently 
(2). Cartilage was used as one of the first models for research 
of in vitro engineered tissues and has shown the earliest 
application for the cell-based therapy mainly due to its cellular 
homogeneity and avascularity (3).
Chondrocytes within their natural environment actively 
synthesize and maintain their surrounding matrix. Mature 
chondrocytes have limited ability to proliferate; they are often 
mislabeled as dormant. In cell culture, human chondrocytes 
regain their ability to proliferate. Thus, the basic premise 
behind Autologous Chondrocyte Implantation (ACI) is to 
overcome the inherent limitations of mature chondrocytes to 
effectively restore an injured articular surface.
In monolayer culture, these cells respond by undergoing 
rapid proliferation. Histologically, these chondrocytes reversibly 
dedifferentiate, assuming a fibroblastic appearance and express 
type I collagen as opposed to type II collagen normally seen in 
articular cartilage. Once removed from the monolayer culture 
and placed in suspension or returned to the articular cartilage 
environment, the cells undergo a re-differentiation process 
into normal appearing chondrocytes and again produce type II 
collagen and proteoglycan aggregates (4).
In 1994 Brittberg et al described the use of ACI in treating 
full-thickness AC defects of the human knee (5). It was achieved 
in a two-stage procedure. Stage 1 involved arthroscopic biopsy 
of healthy AC and cultivation of the chondrocytes to produce 
between 5 and 10 million cells over a period of 4–6 weeks. 
Stage 2 involved debridement of the osteochondral lessions 
and coverage by a periosteal flap followed by open implantation 
of these cells into the AC defect.
Isolation and cultivation of chondrocytes is a widely spread 
technique. It is required in ACI as a treatment for ostheochondritis 
dissecans (6), ostheoarthritis (7) and articular cartilage injuries 
produced by trauma (8). In general, it can be used in any 
articular cartilage injury, where other surgical procedures are 
not sufficient (4). In vitro chondrocyte manipulation is a crucial 
phase of autologous chondrocyte implantation. To minimize 
the risk of in vitro cell contamination, the manipulation must 
be performed in a controlled environment such as a cleanroom 
according to good laboratory practice (GLP). The GLP standards 
provide guidance on implementing GLP requirements critical 
for laboratory operations (9, 10).
In the current study, we have used basic methods 
for isolation and cultivation of chondrocytes from human 
articular cartilage according to GLP standards. Phenotype 
characterization of chondrocytes was performed by flow 
cytometry analysis.
MATERIALS AND METHODS
Work in cleanroom according to GLP standards
Isolation and cultivation of chondrocytes was performed 
in the cleanroom in Associated Tissue Bank of Faculty of 
Medicine of P. J. Šafárik University and L. Pasteur University 
Hospital in Košice, Slovakia. A cleanroom is a controlled 
environment in which the concentration of airborne particles is 
controlled to specified limits (Tab.1). Contaminants generated 
by people, process, facilities and equipment were continually 
removed from the air. Air flow rates, direction, pressurization, 
temperature, humidity and specialized filtration were all 
tightly controlled. Persons and materials entered and exited 
the cleanroom through airlocks (material pass box), gowning 
rooms and they weared special clothing designed to trap 
contaminants that are naturally generated by skin and the 
body. Cells were handled inside biological safety cabinets and 
cultivated in the gas incubators (Fig. 1).
Isolation and cultivation of chondrocytes
Human cartilage tissue was harvested from the lateral 
femoral condyle of 5 patients (an average age: 63 years) 
undergoing total knee replacement surgery due to osteoarthritis 
(stage 3). Cartilage tissue was harvested in accordance with the 
ethical standards of L. Pasteur University Hospital commitee 
on human experimentation in Košice, Slovakia. Cartilage 
tissue was placed into the transport medium containing sterile 
high-glucose Dulbecco’s modified Eagle medium (DMEM; 
Invitrogen, GIBCO, USA) supplemented with 1% antibiotic/
antimycotic solution (10,000 units/mL penicillin, 10,000 µg/mL 
streptomycin, and 25 µg/mL amphotericin B; Invitrogen, GIBCO, 
USA). Cartilage tissue was minced with a scalpel to small pieces 
(1x1x1 mm) and digested with 0,1% bacterial collagenase type 
II (Invitrogen, GIBCO, USA) in Ham’s F-12 (Biochrom AG) for 
20 h at 37 C in 95% air and 5% CO2 humified atmosphere. Cell 
suspension was filtered by 40 µm nylon cell strainer (BD Falcon, 
Biosciences, Bedford, MA) to remove cell raft and matrix debris. 
The filtrate was then centrifuged at 150 x g for 7 min and the 
pellet washed twice with DMEM (Invitrogen, GIBCO, USA). 
Isolated cells were suspended in cell culture medium containing 
Ham’s F-12 (Biochrom AG), 10% fetal bovine serum (FBS; 
Invitrogen, GIBCO, USA), 1% antibiotic/antimycotic solution 
(10,000 units/mL penicillin, 10,000 µg/mL streptomycin, and 25 
µg/mL amphotericin B; Invitrogen, GIBCO, USA) and 1% Insulin-
Transferin-Selenium–A supplement (Invitrogen, GIBCO, USA). 
Chondrocytes were cultivated as a monolayer for expansion in 
37 C humidified incubator with an atmosphere of 95% air and 
5% CO2. The medium was changed 2 times weekly. Confluent 
layers of chondrocytes were dissociated with 0.05% Trypsin-
EDTA solution (Invitrogen, GIBCO®, USA) and the number 
and viability of cells was assessed by TC10™ Automated Cell 
Counter (Bio-Rad Laboratories).
Characterization of chondrocytes
Fig. 1. Cleanroom facilities for cell cultivation according to GLP 
standards
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Phenotype characterization of chondrocytes after first 
passage (P1) was performed by flow cytometry. After detaching 
cells from the tissue culture flasks, the cells were washed 
twice with phosphate buffered saline solution (PBS; Invitrogen, 
GIBCO, USA) supplemented with 2% FBS (Invitrogen, GIBCO, 
USA). Aliquots of 100,000 cells were incubated with mouse 
anti-human CD90-PE (Miltenyi Biotec Inc., USA), mouse anti-
human CD44-PE (Miltenyi Biotec Inc., USA) and mouse anti-
human CD45-FITC (Miltenyi Biotec Inc., USA) for 30 min in the 
dark. Flow cytometric analysis was performed with FACSCalibur 
flow cytometer (Becton Dickinson) and CellQuest software 
(Becton Dickinson). Chondrocytes were considered positive for 
a surface marker when the percentage of positive cells for that 
surface marker was ≥ to 95% and cells were considered negative 
when the percentage of positive cells for that surface marker 
was ≤ to 5%. The level of marker expression was calculated as 
the ratio between geometric mean fluorescence intensity of 
sample cells and that of the negative control.
RESULTS
Chondrocytes isolation and morphology
Cells isolated from human cartilage after enzymatic 
digestion were seeded at 75 cm2 tissue culture flask (T75) at 
density 35,000 cells⁄ cm2. The morphology of chondrocytes was 
observed under an inverted phase contrast light microscope 
(Leica DM IL). Non-adherent or few adherent small round 
cells were also present in the primary culture after 4 days of 
cultivation; these cells were removed with first medium change. 
Heterogeneous population of cells with different morphology 
was observed after 7 days of cultivation (Fig. 2a). After 21 days 
of cultivation chondrocytes had more polygonal structure, even 
though few of cells had spindle/fibroblast like morphology (Fig. 
2b). Chondrocytes reached confluence within 3 to 4 weeks. 
Average number of chondrocytes obtained after trypsinization 
(P1) was 2,23 x 106 ± 0,5 per mL (Tab. 1).
Phenotype characterization of chondrocytes
Flow cytometric analysis showed that chondrocytes were 
positive for CD44 (98,35% ± 0,50), CD90 (97,15% ± 0,13) after 
first passage (P1) and the cells were negative for hematopoietic 
marker CD45 (0,21% ± 0,11) (Fig.3, Tab.1). Data are expressed 
as means ± SD (n=5).
DISCUSSION
The objective of chondrocyte manipulation suitable for 
autologous implantation is to obtain viable and phenotypically 
stable cells able to enhance repair processes in the damaged 
area of human cartilage. Despite the importance of the 
extracellular matrix, the cells are responsible for the balanced 
turnover of the extracellular matrix, which is necessary for 
maintenance of the integrity of the extracellular cartilage. 
In vitro expansion of chondrocytes is possible via monolayer 
culture, whereby the cells alter their morphology and 
metabolism in a process known as dedifferentiation (11). 
The importance of monolayer expansion of cells from small 
biopsies is their clinical application in repair strategies such as 
autologous chondrocyte transplantation (5).
The aim of the present study was to determine if 
chondrocytes isolated from human cartilage of five elderly 
patients with osteoarthritis stage 3 maintain their proliferation 
and chondrogenic potential. It is known that upon digestion of 
the ECM from a cartilage biopsy and subsequent adhesion to 
the culturing surface, chondrocytes re-enter the cell cycle and 
proliferate. Three weeks after cultivation polygonal structures 
typical for chondrocytes were observed, but spindle/fibroblast 
like morphology was also detected in culture. Samples 
derived from aged patients, even in regions of ‘‘normal’’ 
appearing cartilage, are metabolically not truly normal and 
Figure 2. Representative phase-contrast photomicrographs 
(magnification: x100) of cultured human a) chondrocytes, 7 
days of cultivation at P0 (heterogenous population of cells) 
b) chondrocytes, 21 days of cultivation at P0 (spindle and 
polygonal shaped cells) 
Table 1. Characterization of chondrocytes isolated from human 
cartilage of patients with osteoarthritis




2,53 1,62 2,35 1,81 2,82 2,23 0,50
Viability 
(%)
98,00 95,00 99,00 96,00 97,00 97,00 1,58
CD90 (%) 97,32 97,08 97,11 97,24 97,01 97,15 0,13
CD44 (%) 98,00 98,13 98,97 97,87 98,80 98,35 0,50
CD45 (%) 0,12 0,10 0,32 0,30 0,23 0,21 0,10
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that chondrocyte phenotype is not stable in vitro, in particular 
in monolayer culture (12). Most data also suggest that the 
major phenotypic alterations are initially observed in the 
superficial zone of early-stage osteoarthritic cartilage, where 
chondrocytes express de novo abnormal, non-chondrocytic 
genes; in particular, they express the enzymes required for 
degrading the matrix that surrounds the cells as well as many 
of the cytokines and growth factors relevant for turning on 
the catabolic processes within cartilage (13).
Immunophenotype characterization of chondrocytes 
was performed by flow cytometry, which offers the possibility 
to assess and quantify a large number of epitopes on single 
cells within a short period of time. Imunophenotypic analysis 
of cells isolated from solid tissues through enzymatic 
digestions might be compromised due to the reduction or 
even total loss of surface molecules sensitive to enzymatic 
treatment. Collagenase type II used in our study did not 
impair the detection of the CD90, CD44 and CD45 markers. We 
have confirmed expression of the hyaluronan receptor CD44 
and CD 90 (Thy-1) on chondrocytes (1P) as was previously 
reported (14, 15, 16). The hyaluronan receptor CD44 belongs 
to the polymorphic family of CD44 glycoproteins, which have 
been implicated in a variety of cellular functions including 
adhesion to hyaluronan and collagen, and which is present 
in normal chondrocytes (15). It was previously reported 
that CD90 is also expressed in a minority of chondrocytes 
in normal articular cartilage (16). Up-regulation of markers 
on chondrocytes regarded as distinctive for mesenchymal 
stem cells (CD90 among others) during monolayer culture 
suggested that dedifferentiation leads to reversion to a 
primitive phenotype (17). Hematopoietic marker CD45 
known as the leukocyte common antigen was not expressed 
on chondrocytes. CD 45 should not be present in normal 
chondrocytes but can appear in dedifferenciated ones (15).
It is important to enhance that cells used in this study 
were not applied in clinical practice and basic characterization 
of chondrocytes was the only aim. Nevertheless, weakness 
of this study is that we did not include a control of 
healthy articular cartilage and from younger patients with 
osteoarthritis due to the limitation of donors. In spite of, 
some investigators reported irreversible changes in phenotype 
between chondrocytes isolated from OA cartilage versus those 
of young healthy joints (18, 19, 20). Other reports indicate 
comparable proliferation or differentiation potential of OA 
chondrocytes (21, 22).
CONCLUSION
Basics methods of in vitro isolation and cultivation of 
chondrocytes from OA cartilage were realized in this work. 
The present study contains also some limitations. More 
precise characterization of surface and intracellular markers of 
chondrocytes and comparison with a control group of young 
healthy patients should be done. In conclusion, we can assume 
that human articular chondrocytes obtained from elderly patients 
with osteoarthritis (stage 3) maintained a chondrocyte phenotype 
and could be potentially used for autologous implantation. We 
have standardized the conditions for cultivation to minimize the 
risk of in vitro cell contamination according to GLP standards 
since chondrocyte manipulation for autologous implantation 
requires standardised protocols ensuring that the cell product is 
therapeutically effective and safe.
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